HEADER IMMUNE SYSTEM 11-JUN-13 4BSV TITLE HETERODIMERIC FC ANTIBODY AZYMETRIC VARIANT 1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: HETERODIMERIC FC ANTIBODY AZYMETRIC VARIANT 2; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: IG GAMMA 1 FC DOMAIN, RESIDUES 106-330; COMPND 5 ENGINEERED: YES; COMPND 6 MUTATION: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: HETERODIMERIC FC ANTIBODY AZYMETRIC VARIANT 2; COMPND 9 CHAIN: B; COMPND 10 FRAGMENT: IG GAMMA 1 FC DOMAIN, RESIDUES 106-330; COMPND 11 ENGINEERED: YES; COMPND 12 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: CRICETULUS GRISEUS; SOURCE 6 EXPRESSION_SYSTEM_COMMON: CHINESE HAMSTER; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 10029; SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: CHO; SOURCE 9 MOL_ID: 2; SOURCE 10 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 11 ORGANISM_COMMON: HUMAN; SOURCE 12 ORGANISM_TAXID: 9606; SOURCE 13 EXPRESSION_SYSTEM: CRICETULUS GRISEUS; SOURCE 14 EXPRESSION_SYSTEM_COMMON: CHINESE HAMSTER; SOURCE 15 EXPRESSION_SYSTEM_TAXID: 10029; SOURCE 16 EXPRESSION_SYSTEM_CELL_LINE: CHO KEYWDS IMMUNE SYSTEM, ANTIBODY, BISPECIFIC, SCAFFOLD, ANTIBODY ENGINEERING, KEYWDS 2 ZYMEWORKS INC. EXPDTA X-RAY DIFFRACTION AUTHOR M.D.L.SUITS,T.SPRETER,E.E.CABRERA,S.B.DIXIT,P.I.LARIO,D.K.Y.POON, AUTHOR 2 I.E.P.D'ANGELO,M.J.BOULANGER REVDAT 5 20-DEC-23 4BSV 1 HETSYN LINK REVDAT 4 29-JUL-20 4BSV 1 COMPND REMARK HETNAM LINK REVDAT 4 2 1 SITE ATOM REVDAT 3 08-MAY-19 4BSV 1 REMARK LINK REVDAT 2 23-APR-14 4BSV 1 JRNL REVDAT 1 21-AUG-13 4BSV 0 JRNL AUTH T.S.VON KREUDENSTEIN,E.ESCOBAR-CARBRERA,P.I.LARIO, JRNL AUTH 2 I.D'ANGELO,K.BRAULT,J.KELLY,Y.DUROCHER,J.BAARDSNES, JRNL AUTH 3 R.J.WOODS,M.H.XIE,P.GIROD,M.D.L.SUITS,M.J.BOULANGER, JRNL AUTH 4 D.K.Y.POON,G.Y.K.NG,S.B.DIXIT JRNL TITL IMPROVING BIOPHYSICAL PROPERTIES OF A BISPECIFIC ANTIBODY JRNL TITL 2 SCAFFOLD TO AID DEVELOPABILITY: QUALITY BY MOLECULAR DESIGN. JRNL REF MABS V. 5 646 2013 JRNL REFN ISSN 1942-0862 JRNL PMID 23924797 JRNL DOI 10.4161/MABS.25632 REMARK 2 REMARK 2 RESOLUTION. 1.75 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.7.0029 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.75 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 41.38 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.1 REMARK 3 NUMBER OF REFLECTIONS : 53467 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.179 REMARK 3 R VALUE (WORKING SET) : 0.178 REMARK 3 FREE R VALUE : 0.208 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 2849 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.75 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.80 REMARK 3 REFLECTION IN BIN (WORKING SET) : 3575 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 90.38 REMARK 3 BIN R VALUE (WORKING SET) : 0.2150 REMARK 3 BIN FREE R VALUE SET COUNT : 185 REMARK 3 BIN FREE R VALUE : 0.2430 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3458 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 259 REMARK 3 SOLVENT ATOMS : 753 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 25.78 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.27000 REMARK 3 B22 (A**2) : 0.21000 REMARK 3 B33 (A**2) : -0.48000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.041 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.030 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.094 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 2.746 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.958 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.949 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 7378 ; 0.008 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 10038 ; 1.317 ; 2.023 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 836 ;10.688 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 304 ;34.704 ;25.000 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 1160 ;14.760 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 24 ;17.323 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 1174 ; 0.091 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 5330 ; 0.011 ; 0.022 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. IN ORDER TO ACCOMMODATE THE PERFECT 50-50 MIXTURE, REMARK 3 RECIPROCAL RELATIONSHIP OF THE AZYMETRIC HETERODIMER PRESENT IN REMARK 3 THE CRYSTALLOGRAPHIC ASYMMETRIC UNIT, TWO POSSIBLE HETERODIMER REMARK 3 PAIRS, EACH WITH 0.5 ATOMIC OCCUPANCIES, WERE MODELED. FOR REMARK 3 EXAMPLE, THE OCCUPANCY OF MOLECULE A CAN BE EQUALLY BE DESCRIBED REMARK 3 BY MOLECULE B AND VICE VERSA. REMARK 4 REMARK 4 4BSV COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 11-JUN-13. REMARK 100 THE DEPOSITION ID IS D_1290057242. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 12-SEP-12 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : CLSI REMARK 200 BEAMLINE : 08B1-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.98005 REMARK 200 MONOCHROMATOR : KOHZU DOUBLE CRYSTAL REMARK 200 MONOCHROMATOR (DCM), FEATURING REMARK 200 INDIRECTLY WATER- COOLED FIRST REMARK 200 CRYSTAL AND FLAT, LONG SECOND REMARK 200 CRYSTAL REMARK 200 OPTICS : COLLIMATING MIRROR WITH TWO REMARK 200 STRIPES (SI, RH AND PT) REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH MX-300HE REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 56316 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.750 REMARK 200 RESOLUTION RANGE LOW (A) : 47.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 7.300 REMARK 200 R MERGE (I) : 0.04000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 26.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.75 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.84 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 7.40 REMARK 200 R MERGE FOR SHELL (I) : 0.41000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 2J6E REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.82 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.55 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: VIA HANGING DROP VAPOR DIFFUSION REMARK 280 METHOD AT A RATIO OF 2:1 OF 8.5 MG/ML OF AZYMETRIC VARIANT ABOVE REMARK 280 A MOTHER LIQUOR SOLUTION COMPOSED OF 5% (V/V) ETHYLENE GLYCOL, REMARK 280 18% (W/V) POLYETHYLENE GLYCOL 3350, AND 0.15 M AMMONIUM IODIDE REMARK 280 WITH AID OF MICROSEEDING., VAPOR DIFFUSION, HANGING DROP REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 24.77000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 74.46000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 37.46000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 74.46000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 24.77000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 37.46000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3250 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 30010 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -16.9 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D, E, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 222 REMARK 465 THR A 223 REMARK 465 HIS A 224 REMARK 465 THR A 225 REMARK 465 CYS A 226 REMARK 465 PRO A 227 REMARK 465 PRO A 228 REMARK 465 CYS A 229 REMARK 465 PRO A 230 REMARK 465 ALA A 231 REMARK 465 PRO A 232 REMARK 465 GLU A 233 REMARK 465 LEU A 234 REMARK 465 LEU A 235 REMARK 465 GLY A 446 REMARK 465 LYS A 447 REMARK 465 GLY B 222 REMARK 465 THR B 223 REMARK 465 HIS B 224 REMARK 465 THR B 225 REMARK 465 CYS B 226 REMARK 465 PRO B 227 REMARK 465 PRO B 228 REMARK 465 CYS B 229 REMARK 465 PRO B 230 REMARK 465 ALA B 231 REMARK 465 PRO B 232 REMARK 465 GLU B 233 REMARK 465 LEU B 234 REMARK 465 LEU B 235 REMARK 465 GLY B 446 REMARK 465 LYS B 447 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 ASP A 270 C PRO A 271 N -0.216 REMARK 500 ASP B 270 C PRO B 271 N -0.125 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO A 374 C - N - CD ANGL. DEV. = -14.1 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 265 37.47 72.39 REMARK 500 ASP A 280 41.93 34.25 REMARK 500 GLU A 283 131.38 -39.97 REMARK 500 SER A 298 8.07 83.28 REMARK 500 PRO A 374 179.31 -34.51 REMARK 500 PRO A 374 150.69 8.92 REMARK 500 ASN A 434 7.93 57.09 REMARK 500 HIS A 435 17.99 57.56 REMARK 500 ASP B 265 36.95 70.30 REMARK 500 SER B 298 -25.84 86.87 REMARK 500 ALA B 330 168.79 167.30 REMARK 500 LEU B 358 6.22 -68.12 REMARK 500 PRO B 374 175.40 -36.59 REMARK 500 PRO B 374 174.16 -34.35 REMARK 500 ASN B 390 50.97 -117.58 REMARK 500 ASN B 434 14.16 55.78 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 TYR A 373 PRO A 374 -54.62 REMARK 500 TYR A 373 PRO A 374 -79.86 REMARK 500 TYR B 373 PRO B 374 -49.48 REMARK 500 TYR B 373 PRO B 374 -47.69 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: MAIN CHAIN PLANARITY REMARK 500 REMARK 500 THE FOLLOWING RESIDUES HAVE A PSEUDO PLANARITY REMARK 500 TORSION ANGLE, C(I) - CA(I) - N(I+1) - O(I), GREATER REMARK 500 10.0 DEGREES. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 500 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 500 I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI ANGLE REMARK 500 TYR A 373 -12.41 REMARK 500 TYR A 373 -10.58 REMARK 500 TYR B 373 -11.26 REMARK 500 TYR B 373 -10.73 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A4055 DISTANCE = 6.05 ANGSTROMS REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 NAG D 1 REMARK 610 MAN E 1 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4BSW RELATED DB: PDB REMARK 900 HETERODIMERIC FC ANTIBODY AZYMETRIC VARIANT 2 REMARK 999 REMARK 999 SEQUENCE REMARK 999 FC HETERODIMERS WERE CONSTRUCTED VIA INTRODUCTION OF THE REMARK 999 FOLLOWING MUTATIONS - T350V, L351Y, F405A, Y407V (MOLECULE REMARK 999 A, A), AND T350V, T366L, K392M, T394W (MOLECULE A ALT CONFORMER B) REMARK 999 AND T350V, T366L, K392M, T394W (MOLECULE B ALT CONFORMER B) DBREF 4BSV A 223 447 UNP P01857 IGHG1_HUMAN 106 330 DBREF 4BSV B 223 447 UNP P01857 IGHG1_HUMAN 106 330 SEQADV 4BSV GLY A 222 UNP P01857 EXPRESSION TAG SEQADV 4BSV VAL A 350 UNP P01857 THR 233 ENGINEERED MUTATION SEQADV 4BSV TYR A 351 UNP P01857 LEU 234 MICROHETEROGENEITY SEQADV 4BSV LEU A 366 UNP P01857 THR 249 MICROHETEROGENEITY SEQADV 4BSV MET A 392 UNP P01857 LYS 275 MICROHETEROGENEITY SEQADV 4BSV TRP A 394 UNP P01857 THR 277 MICROHETEROGENEITY SEQADV 4BSV ALA A 405 UNP P01857 PHE 288 MICROHETEROGENEITY SEQADV 4BSV VAL A 407 UNP P01857 TYR 290 MICROHETEROGENEITY SEQADV 4BSV GLY B 222 UNP P01857 EXPRESSION TAG SEQADV 4BSV VAL B 350 UNP P01857 THR 233 ENGINEERED MUTATION SEQADV 4BSV TYR B 351 UNP P01857 LEU 234 MICROHETEROGENEITY SEQADV 4BSV LEU B 366 UNP P01857 THR 249 MICROHETEROGENEITY SEQADV 4BSV MET B 392 UNP P01857 LYS 275 MICROHETEROGENEITY SEQADV 4BSV THR B 394 UNP P01857 TRP 277 MICROHETEROGENEITY SEQADV 4BSV ALA B 405 UNP P01857 PHE 288 MICROHETEROGENEITY SEQADV 4BSV VAL B 407 UNP P01857 TYR 290 MICROHETEROGENEITY SEQRES 1 A 226 GLY THR HIS THR CYS PRO PRO CYS PRO ALA PRO GLU LEU SEQRES 2 A 226 LEU GLY GLY PRO SER VAL PHE LEU PHE PRO PRO LYS PRO SEQRES 3 A 226 LYS ASP THR LEU MET ILE SER ARG THR PRO GLU VAL THR SEQRES 4 A 226 CYS VAL VAL VAL ASP VAL SER HIS GLU ASP PRO GLU VAL SEQRES 5 A 226 LYS PHE ASN TRP TYR VAL ASP GLY VAL GLU VAL HIS ASN SEQRES 6 A 226 ALA LYS THR LYS PRO ARG GLU GLU GLN TYR ASN SER THR SEQRES 7 A 226 TYR ARG VAL VAL SER VAL LEU THR VAL LEU HIS GLN ASP SEQRES 8 A 226 TRP LEU ASN GLY LYS GLU TYR LYS CYS LYS VAL SER ASN SEQRES 9 A 226 LYS ALA LEU PRO ALA PRO ILE GLU LYS THR ILE SER LYS SEQRES 10 A 226 ALA LYS GLY GLN PRO ARG GLU PRO GLN VAL TYR VAL TYR SEQRES 11 A 226 PRO PRO SER ARG ASP GLU LEU THR LYS ASN GLN VAL SER SEQRES 12 A 226 LEU THR CYS LEU VAL LYS GLY PHE TYR PRO SER ASP ILE SEQRES 13 A 226 ALA VAL GLU TRP GLU SER ASN GLY GLN PRO GLU ASN ASN SEQRES 14 A 226 TYR LYS THR THR PRO PRO VAL LEU ASP SER ASP GLY SER SEQRES 15 A 226 PHE ALA LEU VAL SER LYS LEU THR VAL ASP LYS SER ARG SEQRES 16 A 226 TRP GLN GLN GLY ASN VAL PHE SER CYS SER VAL MET HIS SEQRES 17 A 226 GLU ALA LEU HIS ASN HIS TYR THR GLN LYS SER LEU SER SEQRES 18 A 226 LEU SER PRO GLY LYS SEQRES 1 B 226 GLY THR HIS THR CYS PRO PRO CYS PRO ALA PRO GLU LEU SEQRES 2 B 226 LEU GLY GLY PRO SER VAL PHE LEU PHE PRO PRO LYS PRO SEQRES 3 B 226 LYS ASP THR LEU MET ILE SER ARG THR PRO GLU VAL THR SEQRES 4 B 226 CYS VAL VAL VAL ASP VAL SER HIS GLU ASP PRO GLU VAL SEQRES 5 B 226 LYS PHE ASN TRP TYR VAL ASP GLY VAL GLU VAL HIS ASN SEQRES 6 B 226 ALA LYS THR LYS PRO ARG GLU GLU GLN TYR ASN SER THR SEQRES 7 B 226 TYR ARG VAL VAL SER VAL LEU THR VAL LEU HIS GLN ASP SEQRES 8 B 226 TRP LEU ASN GLY LYS GLU TYR LYS CYS LYS VAL SER ASN SEQRES 9 B 226 LYS ALA LEU PRO ALA PRO ILE GLU LYS THR ILE SER LYS SEQRES 10 B 226 ALA LYS GLY GLN PRO ARG GLU PRO GLN VAL TYR VAL LEU SEQRES 11 B 226 PRO PRO SER ARG ASP GLU LEU THR LYS ASN GLN VAL SER SEQRES 12 B 226 LEU LEU CYS LEU VAL LYS GLY PHE TYR PRO SER ASP ILE SEQRES 13 B 226 ALA VAL GLU TRP GLU SER ASN GLY GLN PRO GLU ASN ASN SEQRES 14 B 226 TYR MET THR TRP PRO PRO VAL LEU ASP SER ASP GLY SER SEQRES 15 B 226 PHE PHE LEU TYR SER LYS LEU THR VAL ASP LYS SER ARG SEQRES 16 B 226 TRP GLN GLN GLY ASN VAL PHE SER CYS SER VAL MET HIS SEQRES 17 B 226 GLU ALA LEU HIS ASN HIS TYR THR GLN LYS SER LEU SER SEQRES 18 B 226 LEU SER PRO GLY LYS MODRES 4BSV ASN A 297 ASN GLYCOSYLATION SITE MODRES 4BSV ASN B 297 ASN GLYCOSYLATION SITE HET NAG C 1 28 HET FUC C 2 20 HET NAG D 1 28 HET BMA D 2 22 HET MAN D 3 22 HET NAG D 4 28 HET GAL D 5 22 HET MAN E 1 22 HET NAG E 2 28 HET NAG F 1 28 HET NAG F 2 28 HET BMA F 3 22 HET MAN F 4 22 HET NAG F 5 28 HET GAL F 6 22 HET MAN F 7 22 HET NAG F 8 28 HET FUC F 9 20 HET EDO A1455 4 HET EDO A1456 8 HET EDO A1461 4 HET EDO A1462 4 HET EDO B1455 4 HET EDO B1456 8 HET EDO B1457 4 HET EDO B1458 8 HET EDO B1459 4 HET IOD B1460 1 HET IOD B1461 1 HET IOD B1462 2 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM FUC ALPHA-L-FUCOPYRANOSE HETNAM BMA BETA-D-MANNOPYRANOSE HETNAM MAN ALPHA-D-MANNOPYRANOSE HETNAM GAL BETA-D-GALACTOPYRANOSE HETNAM EDO 1,2-ETHANEDIOL HETNAM IOD IODIDE ION HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN FUC ALPHA-L-FUCOSE; 6-DEOXY-ALPHA-L-GALACTOPYRANOSE; L- HETSYN 2 FUC FUCOSE; FUCOSE HETSYN BMA BETA-D-MANNOSE; D-MANNOSE; MANNOSE HETSYN MAN ALPHA-D-MANNOSE; D-MANNOSE; MANNOSE HETSYN GAL BETA-D-GALACTOSE; D-GALACTOSE; GALACTOSE HETSYN EDO ETHYLENE GLYCOL FORMUL 3 NAG 8(C8 H15 N O6) FORMUL 3 FUC 2(C6 H12 O5) FORMUL 4 BMA 2(C6 H12 O6) FORMUL 4 MAN 4(C6 H12 O6) FORMUL 4 GAL 2(C6 H12 O6) FORMUL 7 EDO 9(C2 H6 O2) FORMUL 16 IOD 3(I 1-) FORMUL 19 HOH *753(H2 O) HELIX 1 1 LYS A 246 MET A 252 1 7 HELIX 2 2 LEU A 309 GLY A 316 1 8 HELIX 3 3 SER A 354 LYS A 360 5 7 HELIX 4 4 LYS A 414 GLN A 419 1 6 HELIX 5 5 LEU A 432 ASN A 434 5 3 HELIX 6 6 LYS B 246 MET B 252 1 7 HELIX 7 7 LEU B 309 ASN B 315 1 7 HELIX 8 8 SER B 354 LEU B 358 5 5 HELIX 9 9 LYS B 414 GLN B 419 1 6 HELIX 10 10 LEU B 432 ASN B 434 5 3 SHEET 1 AA 4 SER A 239 PHE A 243 0 SHEET 2 AA 4 GLU A 258 VAL A 266 -1 O THR A 260 N PHE A 243 SHEET 3 AA 4 TYR A 300 THR A 307 -1 O TYR A 300 N VAL A 266 SHEET 4 AA 4 GLU A 293 GLU A 294 1 O GLU A 293 N ARG A 301 SHEET 1 AB 4 SER A 239 PHE A 243 0 SHEET 2 AB 4 GLU A 258 VAL A 266 -1 O THR A 260 N PHE A 243 SHEET 3 AB 4 TYR A 300 THR A 307 -1 O TYR A 300 N VAL A 266 SHEET 4 AB 4 LYS A 288 THR A 289 -1 O LYS A 288 N VAL A 305 SHEET 1 AC 2 GLU A 293 GLU A 294 0 SHEET 2 AC 2 TYR A 300 THR A 307 1 O ARG A 301 N GLU A 293 SHEET 1 AD 4 VAL A 282 VAL A 284 0 SHEET 2 AD 4 VAL A 273 VAL A 279 -1 O TRP A 277 N VAL A 284 SHEET 3 AD 4 TYR A 319 ASN A 325 -1 O LYS A 320 N TYR A 278 SHEET 4 AD 4 ILE A 332 ILE A 336 -1 O ILE A 332 N VAL A 323 SHEET 1 AE 4 GLN A 347 TYR A 351 0 SHEET 2 AE 4 GLN A 362 LYS A 370 -1 N THR A 366 O TYR A 351 SHEET 3 AE 4 LEU A 406 ASP A 413 -1 O SER A 408 N CYS A 367 SHEET 4 AE 4 TYR A 391 THR A 393 -1 N LYS A 392 O LYS A 409 SHEET 1 AF 4 GLN A 386 PRO A 387 0 SHEET 2 AF 4 ALA A 378 SER A 383 -1 O SER A 383 N GLN A 386 SHEET 3 AF 4 PHE A 423 MET A 428 -1 O SER A 424 N GLU A 382 SHEET 4 AF 4 TYR A 436 LEU A 441 -1 O THR A 437 N VAL A 427 SHEET 1 AG 2 VAL A 397 LEU A 398 0 SHEET 2 AG 2 PHE A 404 ALA A 405 -1 N ALA A 405 O VAL A 397 SHEET 1 BA 4 SER B 239 PHE B 243 0 SHEET 2 BA 4 GLU B 258 VAL B 266 -1 O THR B 260 N PHE B 243 SHEET 3 BA 4 TYR B 300 THR B 307 -1 O TYR B 300 N VAL B 266 SHEET 4 BA 4 GLU B 293 GLU B 294 1 O GLU B 293 N ARG B 301 SHEET 1 BB 4 SER B 239 PHE B 243 0 SHEET 2 BB 4 GLU B 258 VAL B 266 -1 O THR B 260 N PHE B 243 SHEET 3 BB 4 TYR B 300 THR B 307 -1 O TYR B 300 N VAL B 266 SHEET 4 BB 4 LYS B 288 THR B 289 -1 O LYS B 288 N VAL B 305 SHEET 1 BC 2 GLU B 293 GLU B 294 0 SHEET 2 BC 2 TYR B 300 THR B 307 1 O ARG B 301 N GLU B 293 SHEET 1 BD 4 VAL B 282 VAL B 284 0 SHEET 2 BD 4 LYS B 274 VAL B 279 -1 O TRP B 277 N VAL B 284 SHEET 3 BD 4 TYR B 319 SER B 324 -1 O LYS B 320 N TYR B 278 SHEET 4 BD 4 ILE B 332 ILE B 336 -1 O ILE B 332 N VAL B 323 SHEET 1 BE 4 GLN B 347 LEU B 351 0 SHEET 2 BE 4 GLN B 362 PHE B 372 -1 N LEU B 366 O LEU B 351 SHEET 3 BE 4 PHE B 404 ASP B 413 -1 O PHE B 404 N PHE B 372 SHEET 4 BE 4 VAL B 397 LEU B 398 1 O VAL B 397 N PHE B 405 SHEET 1 BF 4 GLN B 347 LEU B 351 0 SHEET 2 BF 4 GLN B 362 PHE B 372 -1 N LEU B 366 O LEU B 351 SHEET 3 BF 4 PHE B 404 ASP B 413 -1 O PHE B 404 N PHE B 372 SHEET 4 BF 4 TYR B 391 THR B 393 -1 N MET B 392 O LYS B 409 SHEET 1 BG 2 VAL B 397 LEU B 398 0 SHEET 2 BG 2 PHE B 404 ASP B 413 1 O PHE B 405 N VAL B 397 SHEET 1 BH 4 GLN B 386 PRO B 387 0 SHEET 2 BH 4 ALA B 378 SER B 383 -1 O SER B 383 N GLN B 386 SHEET 3 BH 4 PHE B 423 MET B 428 -1 O SER B 424 N GLU B 382 SHEET 4 BH 4 TYR B 436 LEU B 441 -1 O THR B 437 N VAL B 427 SSBOND 1 CYS A 261 CYS A 321 1555 1555 2.03 SSBOND 2 CYS A 367 CYS A 425 1555 1555 2.04 SSBOND 3 CYS B 261 CYS B 321 1555 1555 2.03 SSBOND 4 CYS B 367 CYS B 425 1555 1555 2.07 LINK ND2AASN A 297 C1 ANAG C 1 1555 1555 1.33 LINK ND2BASN A 297 C1 BNAG C 1 1555 1555 1.58 LINK ND2AASN B 297 C1 ANAG F 1 1555 1555 1.17 LINK O6 ANAG C 1 C1 AFUC C 2 1555 1555 1.42 LINK O6 BNAG C 1 C1 BFUC C 2 1555 1555 1.42 LINK O4 ANAG D 1 C1 ABMA D 2 1555 1555 1.54 LINK O4 BNAG D 1 C1 BBMA D 2 1555 1555 1.39 LINK O6 ABMA D 2 C1 AMAN D 3 1555 1555 1.51 LINK O6 BBMA D 2 C1 BMAN D 3 1555 1555 1.42 LINK O2 AMAN D 3 C1 ANAG D 4 1555 1555 1.44 LINK O2 BMAN D 3 C1 BNAG D 4 1555 1555 1.43 LINK O4 BNAG D 4 C1 BGAL D 5 1555 1555 1.43 LINK O4 ANAG D 4 C1 AGAL D 5 1555 1555 1.48 LINK O2 AMAN E 1 C1 ANAG E 2 1555 1555 1.11 LINK O2 BMAN E 1 C1 BNAG E 2 1555 1555 1.44 LINK O4 BNAG F 1 C1 BNAG F 2 1555 1555 1.41 LINK O4 ANAG F 1 C1 ANAG F 2 1555 1555 1.22 LINK O6 ANAG F 1 C1 AFUC F 9 1555 1555 1.42 LINK O4 ANAG F 2 C1 ABMA F 3 1555 1555 1.43 LINK O4 BNAG F 2 C1 BBMA F 3 1555 1555 1.69 LINK O6 BBMA F 3 C1 BMAN F 4 1555 1555 1.39 LINK O6 ABMA F 3 C1 AMAN F 4 1555 1555 1.41 LINK O3 BBMA F 3 C1 BMAN F 7 1555 1555 1.43 LINK O2 BMAN F 4 C1 BNAG F 5 1555 1555 1.55 LINK O2 AMAN F 4 C1 ANAG F 5 1555 1555 1.43 LINK O4 BNAG F 5 C1 BGAL F 6 1555 1555 1.25 LINK O4 ANAG F 5 C1 AGAL F 6 1555 1555 1.42 LINK O2 BMAN F 7 C1 BNAG F 8 1555 1555 1.28 LINK O2 AMAN F 7 C1 ANAG F 8 1555 1555 1.47 CRYST1 49.540 74.920 148.920 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020186 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013348 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006715 0.00000